Study

Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. – Cost Effective Supplements

Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/23608654


Conclusion of this study

In conclusion, these results show that riboflavin supplementation targeted at hypertensive individuals with the MTHFR 677TT genotype can decrease BP more effectively than treatment with current antihypertensive drugs only and indicate the potential for a personalized approach to the management of hypertension in this genetically at-risk group. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: ISRCTN23620802.


Supplements analyzed in this study

Vitamin B2

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Heart health


Slightly Positive
Vitamin B2


Body systems related to this study


Cardiovascular System
Scroll to top